Sign Up to like & get
recommendations!
0
Published in 2017 at "Bioscience Reports"
DOI: 10.1042/bsr20170958
Abstract: Although galectin-1 and integrin α5β1 confer chemoresistance to certain types of cancer, whether their expression predicts the response to cisplatin-based neoadjuvant chemotherapy (NACT) in squamous cervical cancer remains unclear. Paired tumor samples (pre- and post-chemotherapy)…
read more here.
Keywords:
cisplatin based;
cervical cancer;
squamous cervical;
galectin integrin ... See more keywords